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January 19, 2010:255–69eplicate in a population of patients fulfilling the criteria used in
heir study. We recently evaluated 4,004 patients with interpret-
ble electrocardiograms undergoing treadmill exercise echocardi-
graphy in whom chest pain or ischemic electrocardiographic
hanges during exercise did not develop (3). Applying the criteria
sed in the study by Bourque et al. (1) to this population would
ield 2,005 patients who achieved both 10 METs and 85% of
APHR. Of them, new or worsening wall motion abnormalities
eveloped in 301 (15%) patients, 187 (9.3%) patients had ischemia
nvolving at least 3 myocardial segments, and 138 (6.9%) patients
nderwent coronary revascularization. Thus, these results do not
uggest that a high exercise workload may confidently rule out
yocardial ischemia or significant coronary artery disease in our
atients. It is important to point out that images were acquired at
eak exercise, which enhanced the sensitivity of the tests (4).
Although patients achieving a high exercise workload undoubt-
dly have a better prognosis, a correct diagnosis is still desirable,
ven when coronary revascularization is not deemed necessary. It
ould be interesting to validate the results obtained by Bourque et
l. (1) at other institutions, with different noninvasive imaging
odalities, and using cardiac events or coronary angiography
esults as end points.
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eply
e thank Dr. Bouzas-Mosquera and colleagues for their com-
ents regarding our paper (1). They report the prevalence of
schemic wall-motion abnormalities by stress echocardiography in
studies that seem to have fundamental differences compared with
urs (2,3). One important distinction is the variation in study
ohort clinical characteristics. They analyzed 1 group of 1,433
atients with high exercise capacity and a 30% rate of stress-
nduced wall-motion abnormalities (3). Compared with our pop-
lation, this cohort had a higher prevalence of previous myocardialnfarction (29.0% vs. 11.8%) and included individuals with exercise
T-segment depression (14%) and achievement of 85% of their
aximum age-predicted heart rate (19%). We excluded these types
f patients from our low-risk cohort (1). Their inclusion in the
nalysis by Bouzas-Mosquera and colleagues likely contributed to
he increased ischemia observed in their cohort. Moreover, they
ncluded women who reached only 8 metabolic equivalents
METs) of exercise workload compared with our cutoff of 10
ETs for both men and women. This is an important difference
ecause those patients in our study who achieved 7 to 9 METs of
orkload had a 10-fold increase in the prevalence of 10% left
entricular ischemia (4.3% vs. 0.4%).
The analysis of ischemia in our study was quantitative in nature.
he qualitative (i.e., visual) approach used by Bouzas-Mosquera
t al. (2) is associated with a higher rate of false positives for
schemia, especially in the setting of resting dysfunction, as seen in
revious myocardial infarction.
To match our population more closely, Bouzas-Mosquera et al.
2) examined a second population reaching10 METs and85%
f maximum age-predicted heart rate that expectedly had a lower
revalence of stress wall-motion abnormalities (15%) than in their
ther cohort (30%). It is unclear how many of these positive
chocardiographic studies represent true ischemia versus false
ositivity because the echocardiographic results were not correlated
ith coronary angiography and no cardiac outcomes were pro-
ided. Thus, the 15% ischemia prevalence in this population was
ot validated against a gold standard and seems high for patients
chieving a high workload. In our study, the rate of any ischemia
n such patients was 4.0%, which is more in line with what is
xpected in individuals reaching high exercise workloads and target
eart rate and with what has been described in previous reports.
his suggests that a significant proportion of the stress wall-
otion abnormalities in the study of Bouzas-Mosquera et al. (2)
ay have been falsely positive for ischemia. If there were in fact
uch a high rate of ischemia in their 10 METs cohort (15%), an
ncreased event rate could be expected. Unfortunately, the survival
ata for this subgroup were not provided. Previous prognostic
tudies show low mortality rates in patients with high exercise
apacity.
We agree with Dr. Bouzas-Mosquera and colleagues that
dditional research is necessary to confirm that the very low risk of
ignificant ischemia in our population is associated with a compa-
ably low rate of cardiac events. In fact, we performed a preliminary
utcomes analysis of our cohort that showed no cardiac deaths over
year for subjects achieving 10 METs and 85% maximum
ge-predicted heart rate during exercise stress myocardial perfusion
esting (4).
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linical Classification
f Pulmonary Hypertension
read with interest the recently published Dana Point clinical
lassification of pulmonary arterial hypertension (PAH) in the
ournal supplement (1). Any globally relevant scheme of clinical
lassification cannot and should not lose sight of the prevalence of
he disease state worldwide. Although the classification is not
ased on prevalence, and causes such as left ventricular systolic and
iastolic dysfunction, in which PAH is not of primary importance,
re kept in group 2 only, downgrading PAH associated with
ongenital heart disease (CHD) in their classification scheme to
.4.4 seems unjustified. Although precise epidemiological data are
ot available for most causes of PAH, it is easy to understand the
mportance of PAH due to CHD on a global scale. In 2009, nearly
0% of the world’s population lives in the less and least developed
egions of the world. These regions also have a younger population
rofile, higher growth rates despite high infant mortality, and poor
acilities for the management of CHD. Because the incidence of
HD is more or less uniform at 6 to 8 per 1,000 live births, these
ata easily would translate into a very high burden of PAH
ssociated with CHD in the world, more than any cause listed in
roup 1.4. Most patients with CHD in the Western world
ndergo surgery early in life, and therefore this facet of CHD is
ess and less evident there, but the various aspects of the patho-
enesis of PAH associated with CHD are also far from resolved.
n view of the continued epidemiological, scientific, and pedagog-
cal importance, PAH associated with CHD should be classified as
.4.1 or even higher.
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eply
he relevance of congenital heart disease (CHD) in the setting of
ulmonary arterial hypertension (PAH) is unquestionable, as
tated in the letter by Dr. Kothari. However, it is important to
mphasize that the core structure of the updated clinical classifi-
ation of pulmonary hypertension (1) is not based on the relevance
f the topic or on the prevalence of the disease; thus, there is no
ierarchical level within each one of the groups. The fact that
chistosomiasis-associated PAH is classified as item 1.4.5 does not
ake it more or less important than human immunodeficiency
irus infection–associated PAH, classified as item 1.4.2. The same
an be directly extrapolated to the other 4 groups. Consequently,
ne could not consider that CHD-associated PAH has been
owngraded from the previous classification. This classification has
ven strengthened the role of CHD by describing not only the
natomic-pathophysiologic classification of congenital systemic-
o-pulmonary shunts associated with PAH (see Table 4 in the
lassification [1]) but also the clinical classification of congenital
ystemic-to-pulmonary shunts associated with PAH (see Table 5
n the classification [1]) to disseminate the current knowledge on
he management of such relevant conditions.
The prevalence of the different forms of pulmonary hyperten-
ion is extremely important for the appropriate understanding of
he whole pulmonary hypertension scenario, mainly considering
hat regional characteristics, such as local altitude, sanitary condi-
ions, and health care infrastructure and organization, may play a
ignificant role (2). Even considering that this is not related to the
rder in the updated classification, the commentary from Dr.
othari should be considered as a reinforcement of the need for
obust registries of the different forms of pulmonary hypertension
3) to serve as a basis for international collaborative efforts in the
ulmonary hypertension field.
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